CORRECTION article

Front. Immunol., 27 May 2026

Sec. Autoimmune Disorders

Volume 17 - 2026 | https://doi.org/10.3389/fimmu.2026.1887365

Correction: IgA anti-CD74 autoantibodies are associated with treatment escalation in peripheral psoriatic arthritis

  • 1. Department of Rheumatology and Immunology, Hannover Medical School, Hannover, Germany

  • 2. Department of Microbiology & Immunology, Faculty of Pharmacy, Assiut University, Assiut, Egypt

  • 3. Helmholtz Centre for Infection Research, Braunschweig, Germany

  • 4. Center for Individualized Infection Medicine, a joint venture of Hannover Medical School and the Helmholtz Center for Infection Research, Hannover, Germany

The wrong reference citation was used in section 4 Discussion, paragraph 9. Instead of reference 37, it should have cited reference 36. The corrected sentence reads:

“This interpretation is also supported by previous studies reporting no clear association between anti-CD74 and CRP or disease activity measures (13), repeated predominance of the IgA isotype in anti-CD74 responses (34, 35), and evidence linking CD74 expression to intestinal immune pathways (36), although contradictory data indicate that this mucosal link remains unproven (21).”

Additionally, the wrong reference citation was used in the footnote for Table 4. Instead of reference 38, it should have cited reference 23. The corrected caption of Table 4 appears below:

“BMI was calculated depending on the available height and weight data. BMI categories were defined according to WHO standards: normal weight (<25 kg/m²), overweight (25–29.9 kg/m²), and obese (≥30 kg/m²) (23). Psoriasis outcomes during follow-up were classified as complete resolution, mild activity/improvement, or active disease.”

The original version of this article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

psoriatic arthritis, peripheral psoriatic arthritis, IgA anti-CD74, biomarker, treatment escalation, bDMARDs, csDMARDs

Citation

Elsaghir A, Kuske L, Kniesch K, Rabenow M, Strowig T and Witte T (2026) Correction: IgA anti-CD74 autoantibodies are associated with treatment escalation in peripheral psoriatic arthritis. Front. Immunol. 17:1887365. doi: 10.3389/fimmu.2026.1887365

Received

21 May 2026

Accepted

22 May 2026

Published

27 May 2026

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

17 - 2026

Updates

Copyright

*Correspondence: Alaa Elsaghir,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics